Stock Events

Stock Events

Genethera 

$0
2
+$0+0% Friday 20:00

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
4,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
May 7
$0
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30SepExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.01
-0.01
-0.01
-0
Expected EPS
N/A
Actual EPS
-0.0088

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-1.01MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GTHR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a major player in the pharmaceuticals industry, directly competing in the biotechnology and drug development sectors similar to Genethera.
Merck
MRK
Mkt Cap214.76B
Merck operates in the pharmaceutical and biotech industries, developing medications and vaccines that overlap with Genethera's market.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson engages in the research and development of biopharmaceutical products, competing in the same healthcare sectors as Genethera.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is known for its biopharmaceutical products, directly competing with Genethera in the areas of drug development and innovation.
AMGEN
AMGN
Mkt Cap160.66B
Amgen focuses on human therapeutics, operating in the biotechnology industry and competing in similar biologic and genomic research areas as Genethera.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb, a biopharmaceutical company, develops drugs that treat various diseases, competing with Genethera's therapeutic areas.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that produces drugs in many of the same categories as Genethera, making it a direct competitor.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie operates in the pharmaceutical industry, focusing on advanced therapies that compete with Genethera's product lines.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company develops and manufactures pharmaceutical products, competing with Genethera in drug development and disease treatment.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is involved in healthcare solutions that directly compete with Genethera's interests in biopharmaceuticals and personalized medicine.

About

GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of zoonotic diseases. It offers treatments for zoonotic diseases, such as COVID -19 disease; paratuberculosis (Johne's disease) that is in Stage III clinical phase; mad cow and chronic wasting diseases; and E.coli and salmonella infections, as well as develops vaccine for mycobacterium avium sub paratuberculosis bacteria. The company's Molecular Robotic/AI Platform and Therapeutic strategy is designed to prevent the spread of disease from animals and allow to better control of zoonotic infectious agents. GeneThera, Inc. is based in Westminster, Colorado.
Show more...
CEO
Dr. Antonio Milici M.D., Ph.D.
Employees
2
Country
US
ISIN
US37185E3062

Listings

0 Comments

Share your thoughts

FAQ

What is Genethera stock price today?▼
The current price of GTHR is $0 USD — it has increased by +0% in the past 24 hours. Watch Genethera stock price performance more closely on the chart.
What is Genethera stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Genethera stocks are traded under the ticker GTHR.
What were Genethera earnings last quarter?▼
GTHR earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Genethera revenue for the last year?▼
Genethera revenue for the last year amounts to 0 USD.
What is Genethera net income for the last year?▼
GTHR net income for the last year is -1.01M USD.
Does Genethera pay dividends?▼
Yes, GTHR dividends are paid annual. The last dividend per share was 0 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Genethera have?▼
As of April 03, 2026, the company has 2 employees.
In which sector is Genethera located?▼
Genethera operates in the Health Care sector.
When did Genethera complete a stock split?▼
Genethera has not had any recent stock splits.
Where is Genethera headquartered?▼
Genethera is headquartered in Westminster, US.